Patrick Mahaffy is a seasoned leader in the field of oncology-focused biotechnology with an emphasis on drug development and commercialization in the US and Europe. Having successfully led multiple firms in the industry, each of which was based in Boulder, Colorado, Mr. Mahaffy is now based in South Florida.
Career History An experienced biotech executive, Mahaffy most recently served as CEO of Clovis Oncology, a company he co-founded in 2009. Under his leadership, Clovis developed and marketed a drug for ovarian and prostate cancer in the US and Europe and commenced early-stage clinical development of a targeted radionuclide therapy, an exciting new area of oncology drug development. Unfortunately, the company ultimately wound down in late 2022 due to the